🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +40.14% on $5214.T in just 0m.
CRS
$CRSP
🔒 US EquitiesCRISPR Therapeutics AG
AVG HISTORICAL GAP
+1.32%
MAX GAP RECORD
-8.88%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $CRSP
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$CRSP
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 09, 2026 Earnings Release 2026-11-09 (AFTER CLOSE (21:00)) | 🔮 UPCOMING 🔒 |
| Aug 03, 2026 Earnings Release 2026-08-03 (AFTER CLOSE) |
+1.98%
|
| May 11, 2026 Earnings Release 2026-05-11 (BEFORE OPEN) |
+0.73%
|
| Feb 12, 2026 Earnings Release 2026-02-12 (AFTER CLOSE) |
+1.66%
|
| Nov 10, 2025 Earnings Release 2025-11-10 (BEFORE OPEN) |
+5.33%
|
| Aug 04, 2025 Earnings Release 2025-08-04 (AFTER CLOSE) |
-8.88%
|
| May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE) |
+4.07%
|
| Feb 11, 2025 Earnings Release 2025-02-11 (AFTER CLOSE) |
+2.65%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.0%
Bullish Gaps (11)
Bearish Gaps (2)
Neutral / Flat (1)
📖 Intelligence Summary
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗